Zscaler, Inc. (ZS) Stock Forecast
Data as of Jun 16, 2026Technology · Current price $126.62 (-2.91%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2026 | Eric Heath | KeyBanc | $160.00 | +26.4% |
| Feb 24, 2026 | Gray Powell | BTIG | $209.00 | +65.1% |
| Feb 24, 2026 | Jonathan Ruykhaver | Cantor Fitzgerald | $300.00 | +136.9% |
| Feb 23, 2026 | Todd Weller | Stephens | $225.00 | +77.7% |
| Feb 17, 2026 | Gregg Moskowitz | Mizuho Securities | $265.00 | +109.3% |
| Feb 13, 2026 | Peter Weed | Bernstein | $228.00 | +80.1% |
| Feb 11, 2026 | Matthew Hedberg | RBC Capital | $250.00 | +97.4% |
| Jan 5, 2026 | Matthew Hedberg | RBC Capital | $290.00 | +129.0% |
| Dec 11, 2025 | Almas Almaganbetov | Loop Capital Markets | $320.00 | +152.7% |
| Nov 26, 2025 | Patrick Colville | Scotiabank | $320.00 | +152.7% |
| Nov 26, 2025 | Peter Weed | Bernstein | $264.00 | +108.5% |
| Nov 26, 2025 | Connor Murphy | Capital One Financial | $320.00 | +152.7% |
| Sep 4, 2025 | Kingsley Crane | Canaccord Genuity | $340.00 | +168.5% |
| Sep 3, 2025 | Keith Bachman | BMO Capital | $315.00 | +148.8% |
| Sep 3, 2025 | Adam Borg | Stifel Nicolaus | $330.00 | +160.6% |
| Jun 2, 2025 | Kingsley Crane | Canaccord Genuity | $305.00 | +140.9% |
| May 15, 2025 | Gregg Moskowitz | Mizuho Securities | $250.00 | +97.4% |
| Apr 22, 2025 | Taz Koujalgi | Roth Capital | $215.00 | +69.8% |
| Mar 5, 2025 | Mike Cikos | Needham | $240.00 | +89.5% |
| Nov 18, 2024 | Yun Kim | Loop Capital Markets | $200.00 | +58.0% |
Top Analysts Covering ZS
ZS vs Sector & Market
| Metric | ZS | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.11 | 2.35 | 2.41 |
| Analyst Count | 73 | 14 | 19 |
| Target Upside | +49.9% | +1281.7% | +17.1% |
| P/E Ratio | -321.28 | 38.89 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $3.28B | $3.32B | $3.34B | 35 |
| 2027-07-31 | $3.89B | $3.97B | $4.06B | 37 |
| 2028-07-31 | $4.71B | $4.72B | $4.72B | 28 |
| 2028-10-31 | $915M | $921M | $938M | 12 |
| 2029-01-31 | $925M | $931M | $949M | 13 |
| 2029-04-30 | $936M | $941M | $959M | 13 |
| 2029-07-31 | $946M | $952M | $970M | 15 |
| 2029-10-31 | $957M | $962M | $980M | 18 |
| 2030-01-31 | $967M | $973M | $991M | 19 |
| 2030-04-30 | $978M | $984M | $1.00B | 21 |
| 2030-07-31 | $989M | $995M | $1.01B | 25 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $3.78 | $4.01 | $4.45 | 25 |
| 2027-07-31 | $3.84 | $4.58 | $5.26 | 26 |
| 2028-07-31 | $-8.60 | $5.56 | $29.67 | 11 |
| 2028-10-31 | $0.95 | $0.96 | $0.98 | 17 |
| 2029-01-31 | $0.89 | $0.90 | $0.92 | 16 |
| 2029-04-30 | $0.91 | $0.92 | $0.94 | 12 |
| 2029-07-31 | $1.01 | $1.02 | $1.04 | 18 |
| 2029-10-31 | $1.04 | $1.05 | $1.08 | 12 |
| 2030-01-31 | $1.05 | $1.06 | $1.09 | 12 |
| 2030-04-30 | $1.12 | $1.13 | $1.16 | 19 |
| 2030-07-31 | $1.17 | $1.18 | $1.21 | 12 |
Frequently Asked Questions
What is the analyst consensus for ZS?
The consensus among 73 analysts covering Zscaler, Inc. (ZS) is Buy with an average price target of $282.47.
What is the highest price target for ZS?
The highest price target for ZS is $415.00, set by Freddy Chen at KGI Securities on 2021-11-08.
What is the lowest price target for ZS?
The lowest price target for ZS is $105.00, set by Daniel Ford at UBS on 2023-10-09.
How many analysts cover ZS?
73 analysts have issued ratings for Zscaler, Inc. in the past 12 months.
Is ZS a buy or sell right now?
Based on 73 analyst ratings, ZS has a consensus rating of Buy (2.11/5) with a +49.9% upside to the consensus target of $282.47.
What are the earnings estimates for ZS?
Analysts estimate ZS will report EPS of $4.01 for the period ending 2026-07-31, with revenue estimated at $3.32B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.